JP2005534752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005534752A5 JP2005534752A5 JP2004525093A JP2004525093A JP2005534752A5 JP 2005534752 A5 JP2005534752 A5 JP 2005534752A5 JP 2004525093 A JP2004525093 A JP 2004525093A JP 2004525093 A JP2004525093 A JP 2004525093A JP 2005534752 A5 JP2005534752 A5 JP 2005534752A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- galnac
- binding fragment
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 claims 15
- 150000001875 compounds Chemical class 0.000 claims 12
- 239000000427 antigen Substances 0.000 claims 11
- 108091007433 antigens Proteins 0.000 claims 11
- 102000036639 antigens Human genes 0.000 claims 11
- 230000027455 binding Effects 0.000 claims 11
- 238000000034 method Methods 0.000 claims 9
- 241000589876 Campylobacter Species 0.000 claims 7
- 244000144972 livestock Species 0.000 claims 7
- 241000196324 Embryophyta Species 0.000 claims 6
- 244000052769 pathogen Species 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 239000000523 sample Substances 0.000 claims 4
- 241000282836 Camelus dromedarius Species 0.000 claims 3
- 238000009007 Diagnostic Kit Methods 0.000 claims 3
- 235000017274 Diospyros sandwicensis Nutrition 0.000 claims 3
- 241000282412 Homo Species 0.000 claims 3
- 241000282838 Lama Species 0.000 claims 3
- 241000282826 Camelus Species 0.000 claims 2
- 102000003886 Glycoproteins Human genes 0.000 claims 2
- 108090000288 Glycoproteins Proteins 0.000 claims 2
- 229940024606 amino acid Drugs 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 235000013361 beverage Nutrition 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- PZUPAGRIHCRVKN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-5-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound OCC1OC(O)C(O)C(O)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(COC4C(C(O)C(O)CO4)O)O3)O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(COC2C(C(O)C(O)CO2)O)O1 PZUPAGRIHCRVKN-UHFFFAOYSA-N 0.000 claims 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 206010051226 Campylobacter infection Diseases 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- 238000005481 NMR spectroscopy Methods 0.000 claims 1
- 102000015636 Oligopeptides Human genes 0.000 claims 1
- 108010038807 Oligopeptides Proteins 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003337 fertilizer Substances 0.000 claims 1
- 210000003754 fetus Anatomy 0.000 claims 1
- 239000003673 groundwater Substances 0.000 claims 1
- 238000004008 high resolution magic-angle spinning Methods 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 229960001438 immunostimulant agent Drugs 0.000 claims 1
- 239000003022 immunostimulating agent Substances 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 238000004091 panning Methods 0.000 claims 1
- 244000144977 poultry Species 0.000 claims 1
- 239000002689 soil Substances 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
- 238000004611 spectroscopical analysis Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39973502P | 2002-08-01 | 2002-08-01 | |
| US60/399,735 | 2002-08-01 | ||
| PCT/CA2003/001156 WO2004013151A2 (en) | 2002-08-01 | 2003-07-30 | Campylobacter glycans and glycopeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005534752A JP2005534752A (ja) | 2005-11-17 |
| JP2005534752A5 true JP2005534752A5 (https=) | 2006-09-07 |
| JP4718174B2 JP4718174B2 (ja) | 2011-07-06 |
Family
ID=31495764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004525093A Expired - Fee Related JP4718174B2 (ja) | 2002-08-01 | 2003-07-30 | カンピロバクターグリカンおよびグリコペプチド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7598354B2 (https=) |
| EP (1) | EP1527080B1 (https=) |
| JP (1) | JP4718174B2 (https=) |
| CN (1) | CN1671722A (https=) |
| AU (1) | AU2003254665C1 (https=) |
| BR (1) | BR0312896A (https=) |
| CA (1) | CA2494223C (https=) |
| ES (1) | ES2391525T3 (https=) |
| WO (1) | WO2004013151A2 (https=) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214660B2 (en) * | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| KR20090110951A (ko) | 2002-03-07 | 2009-10-23 | 아이드게노쉬쉐 테흐니쉐 호흐슐레 쥬리히 | 원핵 숙주에서의 재조합 글리코실화 단백질 생산 방법 및 생산계 |
| AU2002952121A0 (en) * | 2002-10-17 | 2002-10-31 | Alchemia Limited | Novel carbohydrate based anti-bacterials |
| EP2055189A1 (en) | 2003-04-09 | 2009-05-06 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
| US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| US20080015142A1 (en) * | 2003-12-03 | 2008-01-17 | Defrees Shawn | Glycopegylated Follicle Stimulating Hormone |
| WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| US20080176790A1 (en) | 2004-10-29 | 2008-07-24 | Defrees Shawn | Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf) |
| US9029331B2 (en) | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| US20070154992A1 (en) | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| CA2607595C (en) * | 2005-05-11 | 2018-11-27 | Eth Zuerich | Recombinant n-glycosylated proteins from procaryotic cells |
| US20070105755A1 (en) * | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| WO2007056191A2 (en) | 2005-11-03 | 2007-05-18 | Neose Technologies, Inc. | Nucleotide sugar purification using membranes |
| ES2516694T3 (es) | 2006-07-21 | 2014-10-31 | Ratiopharm Gmbh | Glicosilación de péptidos a través de secuencias de glicosilación con unión en O |
| US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
| KR20100016160A (ko) | 2007-04-03 | 2010-02-12 | 바이오제너릭스 에이지 | 글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법 |
| WO2008154639A2 (en) | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Improved process for the production of nucleotide sugars |
| CN107119095B (zh) | 2008-01-03 | 2022-07-05 | 康乃尔研究基金会有限公司 | 原核生物中的糖基化蛋白表达 |
| CA2711503A1 (en) * | 2008-01-08 | 2009-07-16 | Biogenerix Ag | Glycoconjugation of polypeptides using oligosaccharyltransferases |
| HRP20181259T1 (hr) | 2008-02-20 | 2018-10-05 | Glaxosmithkline Biologicals S.A. | Biokonjugati načinjeni iz rekombinantnih n-glikoziliranih proteina iz prokariotskih stanica |
| KR101582841B1 (ko) | 2008-02-27 | 2016-01-11 | 노보 노르디스크 에이/에스 | 콘쥬게이트된 인자 ｖｉｉｉ 분자 |
| EP2411503B1 (en) | 2009-03-27 | 2017-09-13 | Eidgenössische Technische Hochschule Zürich | Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
| EP2501406B8 (en) | 2009-11-19 | 2018-01-24 | GlaxoSmithKline Biologicals S.A. | Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| ES2535543T3 (es) | 2010-02-11 | 2015-05-12 | The Governors Of The University Of Alberta | Compuestos de glicano N-enlazado |
| US8841099B2 (en) * | 2010-04-20 | 2014-09-23 | National Research Council Of Canada | Cell-based production of nonulosonates |
| JP6339366B2 (ja) | 2010-05-06 | 2018-06-06 | グリコヴァキシン アーゲー | 莢膜グラム陽性菌のバイオコンジュゲートワクチン |
| US9308246B2 (en) | 2010-05-28 | 2016-04-12 | The United States Of America As Represented By The Secretary Of The Navy | Capsule composition for use as immunogen against Campylobacter jejuni |
| JP6135046B2 (ja) * | 2012-04-20 | 2017-05-31 | 株式会社島津製作所 | 糖ペプチドの質量分析法 |
| US10258680B2 (en) | 2013-04-05 | 2019-04-16 | The Governors Of The University Of Alberta | Campylobacter vaccine |
| JP6722697B2 (ja) * | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
| WO2017117539A1 (en) | 2015-12-30 | 2017-07-06 | Northwestern University | Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation |
| US10829795B2 (en) | 2016-07-14 | 2020-11-10 | Northwestern University | Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates |
| WO2019035916A1 (en) | 2017-08-15 | 2019-02-21 | Northwestern University | DESIGN OF PROTEIN GLYCOSYLATION SITES BY RAPID EXPRESSION AND CHARACTERIZATION OF N-GLYCOSYLTRANSFERASES |
| WO2019119134A1 (en) * | 2017-12-19 | 2019-06-27 | The Governors Of The University Of Alberta | Clostridium perfringens surface glycans and uses thereof |
| US11530432B2 (en) | 2018-03-19 | 2022-12-20 | Northwestern University | Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates |
| WO2019204346A1 (en) | 2018-04-16 | 2019-10-24 | Northwestern University | METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES |
| US12098433B2 (en) | 2018-08-03 | 2024-09-24 | Northwestern University | On demand, portable, cell-free molecular sensing platform |
| CA3126492A1 (en) | 2019-01-11 | 2020-07-16 | Northwestern University | Bioconjugate vaccines synthesis in prokaryotic cell lysates |
| WO2020185451A2 (en) | 2019-03-04 | 2020-09-17 | Northwestern University | Riboswitch-based fluoride sensing in cell-free extract |
| US12226410B2 (en) | 2019-10-18 | 2025-02-18 | Northwestern University | Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6 |
| US12503715B2 (en) | 2019-10-25 | 2025-12-23 | Northwestern University | Cell-free extract preparation protocol for enrichment of membrane vesicles and increased glycoprotein yields |
| US20240287564A1 (en) * | 2021-06-07 | 2024-08-29 | The University Of British Columbia | Acholetin biopolymers and methods for enzymatic synthesis |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925796A (en) * | 1986-03-07 | 1990-05-15 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
| US5200344A (en) * | 1990-11-13 | 1993-04-06 | Blaser Martin J | Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| CA2167691A1 (en) * | 1993-08-27 | 1995-03-02 | Martin J. Blaser | Campylobacter jejuni antigens, and methods for their production and use |
| US5882902A (en) * | 1994-09-06 | 1999-03-16 | Bioflexin Ab | Amino acid conjugate |
| US5840547A (en) * | 1995-01-05 | 1998-11-24 | Ramot University Authority For Applied Research & Indfustrial Development Ltd. | Bioemulsifiers |
| US6676946B2 (en) * | 1997-03-27 | 2004-01-13 | Institut Pasteur | Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
| US6699705B2 (en) * | 1999-02-01 | 2004-03-02 | National Research Council Of Canada | Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| EP1159002A2 (en) * | 1999-03-05 | 2001-12-05 | Trustees Of Tufts College | Emulsan and emulsan analogs immunization formulations and use |
| US6512014B2 (en) * | 2000-12-13 | 2003-01-28 | Ramot University Authority For Applied Research And Industrial Development Limited | Compositions containing bioemulsifiers and a method for their preparation |
| EP2042196B1 (en) * | 2001-10-10 | 2016-07-13 | ratiopharm GmbH | Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| US20030232401A1 (en) * | 2002-06-12 | 2003-12-18 | Pugia Michael J. | Bacterial test method by glycated label binding |
| AU2006295017B2 (en) * | 2005-09-21 | 2010-06-17 | The United States Of America As Represented By The Secretary Of The Navy | Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni |
-
2003
- 2003-07-30 EP EP03766087A patent/EP1527080B1/en not_active Expired - Lifetime
- 2003-07-30 CA CA2494223A patent/CA2494223C/en not_active Expired - Lifetime
- 2003-07-30 ES ES03766087T patent/ES2391525T3/es not_active Expired - Lifetime
- 2003-07-30 BR BR0312896-2A patent/BR0312896A/pt not_active IP Right Cessation
- 2003-07-30 JP JP2004525093A patent/JP4718174B2/ja not_active Expired - Fee Related
- 2003-07-30 WO PCT/CA2003/001156 patent/WO2004013151A2/en not_active Ceased
- 2003-07-30 US US10/523,459 patent/US7598354B2/en not_active Expired - Lifetime
- 2003-07-30 CN CNA038181851A patent/CN1671722A/zh active Pending
- 2003-07-30 AU AU2003254665A patent/AU2003254665C1/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005534752A5 (https=) | ||
| CA2494223A1 (en) | Campylobacter glycans and glycopeptides | |
| Lee et al. | Causative agents and epidemiology of diarrhea in Korean native calves | |
| Leitner et al. | Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial | |
| Muscatello | Rhodococcus equi pneumonia in the foal–part 2: diagnostics, treatment and disease management | |
| US8246963B2 (en) | Vaccine for Edwardsiella disease and streptococcal disease in fish | |
| HU230199B1 (hu) | A Lawsonia intracellularis tenyésztése, anti-Lawsonia intracellularis vakcinák és diagnosztikumok | |
| PH12015501888B1 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
| TNSN03154A1 (fr) | Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux. | |
| ES2527470T3 (es) | Composición farmacéutica que comprende un inhibidor de la bomba de protones y un prebiótico para el tratamiento de lesiones ulcerosas del estómago y el duodeno | |
| CA2257826A1 (en) | Helicobacter pylori adhesin binding group antigen | |
| CN102139103B (zh) | 半滑舌鳎美人鱼发光杆菌疫苗的制备与使用方法 | |
| CN101002947B (zh) | 一种用于细菌病治疗的靶向药物及其制备方法 | |
| JP2006525981A (ja) | アリシン | |
| CN113908121A (zh) | 一种氯硝柳胺注射液及其制备和应用 | |
| TW200423950A (en) | Antidiarrheal composition | |
| RU2425148C2 (ru) | Штамм brucella abortus уф-1 для приготовления биологических препаратов для диагностики и специфической профилактики бруцеллеза сельскохозяйственных животных | |
| CN109913391B (zh) | 罗非鱼源海豚链球菌弱毒株及应用 | |
| JP7021283B2 (ja) | 魚類の連鎖球菌病予防用新規血清型ワクチン | |
| CN116555081A (zh) | 猪链球菌菌株及防治猪链球菌病的多价疫苗及其应用 | |
| Tarello et al. | Corynebacterium pseudotuberculosis and Corynebacterium renale isolated from two Arabian oryx (Oryx leucoryx) | |
| RU2179846C2 (ru) | Средство для профилактики и лечения желудочно-кишечных и респираторных заболеваний телят | |
| CN101780266A (zh) | 防治畜禽呼吸道疾病的复方制剂 | |
| KR102003795B1 (ko) | 신규한 시가톡신 생성 대장균 특이 박테리오파지 ecoh1 및 이를 포함하는 항균 조성물 | |
| RU2429871C1 (ru) | Препарат для лечения желудочно-кишечных болезней телят и способ его применения |